Plante Moran Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1K Buy
179
+4
+2% +$266 ﹤0.01% 540
2026
Q1
$11K Hold
175
﹤0.01% 505
2025
Q4
$11.6K Hold
175
﹤0.01% 538
2025
Q3
$11.8K Hold
175
﹤0.01% 531
2025
Q2
$15.3K Hold
175
﹤0.01% 508
2025
Q1
$12K Hold
175
﹤0.01% 542
2024
Q4
$13.6K Hold
175
﹤0.01% 536
2024
Q3
$11.7K Hold
175
﹤0.01% 593
2024
Q2
$19.8K Hold
175
﹤0.01% 482
2024
Q1
$24.3K Buy
175
+148
+548% +$18.6K ﹤0.01% 470
2023
Q4
$3.35K Buy
+27
New +$2.76K ﹤0.01% 679
2023
Q3
Sell
-28
Closed -$3.6K 786
2023
Q2
$3.6K Buy
+28
New +$3.39K ﹤0.01% 652
2023
Q1
Sell
-152
Closed -$17.2K 815
2022
Q4
$17.2K Buy
+152
New +$16.7K ﹤0.01% 493
2022
Q3
Sell
-32
Closed -$2K 903
2022
Q2
$2K Buy
+32
New +$2.92K ﹤0.01% 807
2022
Q1
Sell
-84
Closed -$11K 848
2021
Q4
$11K Buy
84
+44
+110% +$6.32K ﹤0.01% 671
2021
Q3
$5K Hold
40
﹤0.01% 778
2021
Q2
$4K Hold
40
﹤0.01% 811
2021
Q1
$4K Buy
+40
New +$3.75K ﹤0.01% 802

Other funds holding DXCM

Plante Moran Financial Advisors's DXCM Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its DexCom (DXCM) stake by 2.3% in Q2 2026, buying an estimated $266 and bringing the position to 179 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Plante Moran Financial Advisors first reported a position in DXCM in Q1 2021 and has held it in 18 quarters since. The position peaked at $24.3K in Q1 2024. 526 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Plante Moran Financial Advisors held 179 shares of DexCom worth $12.1K as of Q2 2026.
  • Plante Moran Financial Advisors bought 4 DexCom shares in Q2 2026, an estimated $266.
  • DexCom made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #540 holding.
  • Plante Moran Financial Advisors first reported a position in DexCom in Q1 2021 and has held it in 18 quarters since.
  • Plante Moran Financial Advisors's DexCom position peaked at $24.3K in Q1 2024.
  • 526 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.